As Tau seeds have been demonstrated to be present in brains of AD/Tauopathy patients [26, 45] using a similar assay as in Tau transgenic mice, we anticipate that in brains of patients Tau seeds may activate ASC inflammasome and contribute to Tau-seeded Tau pathology. Here, MAPT is linked to tauopathy.